Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 47.83B | 52.95B | 43.63B | 42.40B | 37.19B | 44.82B |
Gross Profit | 4.52B | 4.82B | 3.79B | 4.02B | 3.99B | 3.88B |
EBITDA | 2.26B | 2.52B | 1.73B | 1.97B | 2.06B | 1.85B |
Net Income | 1.53B | 1.71B | 1.10B | 1.90B | 1.31B | 693.00M |
Balance Sheet | ||||||
Total Assets | 35.98B | 42.87B | 30.34B | 34.86B | 32.45B | 36.00B |
Cash, Cash Equivalents and Short-Term Investments | 4.31B | 3.93B | 6.27B | 7.83B | 5.42B | 4.40B |
Total Debt | 2.73B | 5.98B | 1.93B | 4.42B | 4.46B | 5.01B |
Total Liabilities | 19.38B | 25.57B | 14.56B | 20.40B | 19.77B | 24.65B |
Stockholders Equity | 16.60B | 17.29B | 15.77B | 14.45B | 12.67B | 11.35B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -6.29B | 1.51B | 1.80B | 1.57B | 2.26B |
Operating Cash Flow | 0.00 | -6.13B | 1.52B | 1.82B | 1.60B | 2.28B |
Investing Cash Flow | 0.00 | -137.00M | -507.00M | 711.00M | -33.00M | -26.00M |
Financing Cash Flow | 0.00 | 3.93B | -2.57B | -125.00M | -551.00M | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥14.04B | 7.39 | 1.26% | 23.15% | 46.68% | ||
80 Outperform | ¥10.94B | 5.07 | 2.01% | 24.64% | 35.00% | ||
75 Outperform | ¥10.58B | 10.28 | 4.52% | 3.49% | 9.50% | ||
72 Outperform | ¥10.51B | 9.95 | 4.36% | -4.01% | 42.07% | ||
69 Neutral | ¥9.69B | 34.39 | 0.56% | 20.06% | -17.21% | ||
64 Neutral | $10.96B | 16.35 | 8.89% | 1.96% | 2.68% | -15.17% | |
63 Neutral | ¥9.58B | 3.81 | 2.39% | 12.27% | 682.78% |